FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1269001007: Dapagliflozin propanediol anhydrous (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5182277013 Dapagliflozin propanediol anhydrous en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5182278015 Dapagliflozin propanediol anhydrous (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dapagliflozin propanediol anhydrous Is a Sodium glucose cotransporter subtype 2 inhibitor true Inferred relationship Some
Dapagliflozin propanediol anhydrous This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Some
Dapagliflozin propanediol anhydrous This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dapagliflozin propanediol true Inferred relationship Some
Dapagliflozin propanediol anhydrous Is a Substance with ether structure true Inferred relationship Some
Dapagliflozin propanediol anhydrous Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start